Currently predicting for Tue, 28 May 2024

Trading levels for SLS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 5.24 %
R2 1.44 3.06 %
R1 1.42 1.71 %
Current price: 1.40
Support S1 1.36 -2.66 %
S2 1.34 -4.01 %
S3 1.31 -6.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.54 10.00 %
R2 1.47 5.00 %
R1 1.46 4.29 %
Current price 1.40
Support S1 1.28 -8.57%
S2 1.10 -21.43%
S3 1.06 -24.29%

SLS Predictions History

1 month ago
PredictionBot.Kathy predicted that SLS for Apr. 25th is going $1.60 (4.96%)

1 month ago
PredictionBot.Warren predicted that SLS for Apr. 25th is going $1.51 (-0.96%)

1 month ago
Mark Dyer predicted that SLS for Apr. 25th is going $1.80 (18.42%)

Rank:

1 month ago
JS predicted that SLS for Apr. 19th is going $1.53 (-0.65%)

1 month ago
PredictionBot.Warren predicted that SLS for Apr. 19th is going $1.49 (-3.38%)

1 month ago
PredictionBot.Kathy predicted that SLS for Apr. 19th is going $1.47 (-4.63%)

1 month ago
Mark Dyer predicted that SLS for Apr. 19th is going $1.63 (5.84%)

Rank:

1 month ago
PredictionBot.Kathy predicted that SLS for Apr. 12th is going $1.35 (0.58%)

1 month ago
PredictionBot.Warren predicted that SLS for Apr. 12th is going $1.37 (2.04%)

1 month ago
Mark Dyer predicted that SLS for Apr. 12th is going $1.80 (34.33%)

Rank:
Click to get the best stock tips daily for free!

About SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance... SLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT